Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.

Revenue
+8.45%
EPS
+19.4%
Free cash flow
−0.16%
Total debt
−1.06%

Quarter to September 2026, against a year earlier

461.71 1.43 +0.31%
Market cap
$248.8B
P/E
26.6×
Fwd P/E
29.6×
Dividend yield
2.15%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
14.61 67.30 15.34 18.62 18.56 21.72 21.48 23.68 34.20 22.84
Piotroski F-Score
8 6 8 6 6 6 6 5 5 7
P/S ratio
4.90 5.66 5.42 6.24 5.30 4.94 5.35 5.64 4.19 4.79
Altman Z-Score
2.62 2.61 2.36 2.29 2.10 1.83 1.77 1.34 1.26 1.69
Altman Z″-Score (non-manufacturers)
4.43 4.44 2.78 0.74 1.04 0.43 0.27 0.53 0.05 0.14
P/FCF ratio
12.28 12.84 12.71 18.01 14.25 16.14 16.86 22.98 14.05 22.97
Beneish M-Score
(2.65) (3.02) (2.62) (2.18) (2.65) (2.65) (2.63) (2.26) (2.83) (2.27)
P/Operating CF
36.37 42.96 40.29 58.01 62.58 45.67 53.14 295.73 29.34 109.85
Dividend Safety Score
— — — — — — — — — 56
P/B ratio
3.77 5.13 10.29 15.08 14.32 19.14 38.45 25.53 23.82 20.34
EV/Sales
4.75 5.39 5.61 7.14 6.18 5.91 6.47 7.55 5.63 6.03
EV/EBITDA
9.18 10.32 10.92 14.04 12.33 13.91 13.13 16.60 14.46 14.34
EV/FCF
11.90 12.21 13.17 20.60 16.61 19.32 20.41 30.73 18.88 28.90
Current Ratio
4.11 5.49 2.79 1.44 1.81 1.59 1.41 1.65 1.26 1.14
Net Debt/EBITDA
(0.29) (0.53) 0.38 1.77 1.75 2.29 2.28 4.19 3.70 2.94
Debt/Equity
1.16 1.40 2.71 3.09 3.51 4.97 10.64 10.37 10.23 6.31
ROE
26.65% 7.18% 44.48% 70.73% 76.13% 73.16% 126.47% 135.79% 67.55% 106.10%
ROA
10.36% 2.51% 11.47% 12.44% 11.84% 9.50% 10.38% 8.28% 4.33% 8.45%
ROIC
23.20% 32.97% 37.46% 19.72% 17.99% 14.93% 17.95% 8.24% 8.40% 10.48%
Return on Tangible Assets
19.42% 4.35% 28.86% 74.45% 50.51% 47.58% 54.94% 37.57% 32.79% 67.16%
Average Days of Receivables
50.25 51.71 55.03 63.39 64.96 68.77 77.14 94.11 74.06 95.05
Earnings Yield
6.85% 1.49% 6.52% 5.37% 5.39% 4.61% 4.66% 4.22% 2.92% 4.38%
Free Cash Flow Yield
8.14% 7.79% 7.87% 5.55% 7.02% 6.20% 5.93% 4.35% 7.12% 4.35%
Free Cash Flow per Share
12.86 14.38 15.97 14.10 16.88 14.70 16.33 13.76 19.36 15.06
Book value per Share
39.94 34.53 18.91 15.99 16.06 11.75 6.80 11.65 10.94 16.09
Free Cash Flow
9,616.00 10,513.00 10,558.00 8,532.00 9,889.00 8,381.00 8,785.00 7,359.00 10,394.00 8,100.00
EV/EBIT
11.16 12.34 12.99 17.25 17.19 20.09 17.81 26.94 25.91 24.40
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026